Earnings Outlook For Champions Oncology
Portfolio Pulse from Benzinga Insights
Champions Oncology (NASDAQ:CSBR) is expected to report a quarterly earnings per share (EPS) of $-0.15 on March 12, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historically, the company's share price has reacted to both its earnings performance and the guidance provided. Last quarter, CSBR beat the EPS estimate by $0.02, resulting in a 5.42% share price increase the following day. Over the last 52 weeks, CSBR shares have increased by 30.39%, trading at $5.7 as of March 08.
March 11, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Champions Oncology is anticipated to report a quarterly EPS of -$0.15 on March 12, 2024. The company's past performance and the upcoming earnings announcement could influence its stock price, especially if it beats the EPS estimate and provides positive future guidance.
Given CSBR's history of beating EPS estimates and the subsequent positive reaction in its stock price, a similar outcome could be expected if the company beats the EPS estimate again and provides optimistic future guidance. The historical data suggests that the company's stock price is sensitive to its earnings performance and guidance, making this upcoming report particularly significant for short-term price movement.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100